Prev Chronic Dis by Falci, Laura et al.
PREVENTING  CHRONIC  DISEASE
P U B L I C  H E A L T H  R E S E A R C H ,  P R A C T I C E ,  A N D  P O L I C Y 





Multiple Chronic Conditions and Use of
Complementary and Alternative Medicine
Among US Adults: Results From the 2012




Suggested citation for  this  article:  Falci L,  Shi Z,  Greenlee H.
Multiple  Chronic  Conditions  and  Use  of  Complementary  and
Alternative Medicine Among US Adults: Results From the 2012





More than 25% of American adults report having 2 or more chron-
ic conditions. People with chronic conditions often use comple-
mentary and alternative medicine (CAM) for self-care and disease
management, despite a limited evidence base.
Methods
Data from the 2012 National Health Interview Survey (NHIS) (n =
33,557) were analyzed to assess associations between presence of
multiple chronic conditions (n = 13) and CAM use, using mul-
tivariable relative risk and linear regressions weighted for com-
plex NHIS sampling. CAM use was defined as self-reported use of
one or more of 16 therapies in the previous 12 months.
Results
Chronic conditions were common. US adults reported one (22.3%)
or 2 or more (33.8%) conditions. Many used at least one form of
CAM. Multivitamins, multiminerals, or both (52.7%); vitamins
(34.8%); and minerals  (28.4%) were the most  common. Com-
pared with adults with no conditions, adults with 2 or more condi-
tions were more likely to use multivitamins or multiminerals or
both, vitamins, minerals, nonvitamins or herbs, mind–body ther-
apies, chiropractic or osteopathic manipulation, massage, move-
ment therapies, special diets,  acupuncture, naturopathy, or some
combination of these therapies (P <.003).
Conclusion
People with multiple chronic conditions have a high prevalence of
CAM use. Longitudinal studies are needed to understand the asso-
ciation between CAM use and chronic disease prevention and
treatment.
Introduction
In 2012, more than 25% of US adults reported having 2 or more
chronic conditions, which increased from 22% in 2001 (1,2). Be-
cause of this increase, the Department of Health and Human Ser-
vices (DHHS) formed the Multiple Chronic Conditions Working
Group to compile a list of chronic conditions to improve disease
management and quality of life for people with chronic comorbid
conditions (3,4).
People with multiple chronic conditions face health care burdens
because of the complexity of coordinating disease management,
including treatment by medical professionals and self-care (3). Pri-
or studies show that people with chronic conditions (5–14) often
use complementary and alternative medicine (CAM) therapies as
part of disease management. CAM therapies refer to a number of
approaches not part of mainstream conventional medicine, used
either in complement with or in lieu of standard medical treat-
ments (15). Studies to date suggest that people with chronic condi-
tions are more likely to use CAM, and people with additional con-
ditions  have  an  increased  likelihood  of  overall  CAM  use
(5,7,8,9,11,16–18).  However,  one  study  among  patients  with
chronic liver disease showed an inverse association between addi-
tional comorbidities and current CAM use (19).
The aim of this study was to determine the association between
use of CAM therapies and multiple chronic conditions in a large
nationally representative population of US adults. To our know-
ledge, no studies have examined specific CAM therapy use with
comorbid conditions. Studies examining comorbid conditions and
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CAM use have collapsed CAM into any use versus no use, where-
as in reality, CAM therapies represent a heterogeneous group of
behaviors that differ in type, usage, and bodies of evidence on ef-
ficacy.  Understanding use of  specific  CAM modalities  among
people with multiple chronic conditions could increase know-
ledge about CAM therapies and disease management.
Methods
The 2012 National  Health  Interview Survey (NHIS)  (20)  is  a
cross-sectional household survey conducted annually by the Cen-
ters for Disease Control and Prevention of the US noninstitutional-
ized, civilian population. The NHIS uses a complex sampling pro-
cedure to obtain a nationally representative sample (21). Since
2002 and every 5 years thereafter, the NHIS has included a survey
supplement  on  CAM  use.  The  2012  NHIS  data  set  included
34,525 adults (people aged 18 or older). People were excluded
from this analysis if they had missing data on all CAM variables
(n = 968), leaving a final sample size of 33,557.
The number of chronic conditions was calculated by using the list
developed by the Multiple Chronic Conditions Working Group
(4). Of the 20 chronic conditions listed by the working group, 13
conditions were ascertained in the NHIS 2012 interview (4,20).
The chronic condition variables selected from the 2012 data set
were those that best reflected the definition of a chronic condition
(4). Participants self-reported having ever been told by a physi-
cian they had the following conditions: hypertension 2 times or
more, cancer (excluding nonmelanoma skin cancer), chronic ob-
structive pulmonary disease (COPD, emphysema, or chronic bron-
chitis in the past 12 months), diabetes, hepatitis, coronary heart
disease (CHD), stroke, arthritis, depression, high cholesterol; and
any of the following conditions in the past 12 months: asthma at-
tack, weak or failing kidneys, or substance abuse (20). In 2012,
because of the CAM supplement being included in the NHIS, ad-
ditional conditions were assessed that are on the DHHS list but not
usually ascertained, including high cholesterol, depression, and
substance abuse. A composite variable summed the number of
chronic conditions each subject reported (range, 0–13). It was con-
servatively assumed that any missing value for a single condition
would be recoded as a “no” response. The composite variable was
categorized into 3 levels: none, 1, and 2 or more of the 13 selec-
ted chronic conditions.
The NHIS contains dichotomous (yes/no) information on use of 20
different CAM therapies: body-based therapies including chiro-
practic or osteopathic manipulation, massage, acupuncture, and
movement therapy; mind–body therapies including yoga, tai chi,
qi gong, energy healing therapy, hypnosis, and biofeedback; al-
ternative therapies including Ayurvedic medicine, chelation ther-
apy, craniosacral therapy, homeopathy, naturopathy, and tradition-
al healing; dietary supplements including vitamins, minerals, mul-
tivitamin or multimineral, and other nonvitamin or herbal ther-
apies; and special diets. Energy healing therapy, biofeedback, hyp-
nosis, yoga, tai chi,  qi gong, and mind–body therapies such as
guided relaxation were collapsed into one mind–body therapy
variable  because  they  are  similar  behavioral  CAM  therapies.
Therefore, this analysis examined 16 dichotomous CAM therapy
outcome variables, defined as using a therapy or seeing a practi-
tioner for the modality or both in the past 12 months. A CAM use
index was created by summing the number of CAM therapies each
individual used (range, 0–16). It was assumed that any missing
value for a single therapy would be recoded as a “no” response.
The definition of CAM therapies is largely based on the classifica-
tions of the National Center for Complementary and Integrative
Health (15), though these analyses also include the use of vitam-
ins, minerals, and multivitamins because of their high prevalence
of use. The inclusion of vitamins, minerals, and multivitamins in
the definition of CAM varies in the literature. More than 50% of
the US population uses dietary supplements including multivitam-
ins or minerals and singular vitamin and mineral supplements, and
this use has increased over the past 20 years (22). Because use is
so widespread and the risk for supplements to interact with stand-
ard pharmaceutical treatments is high (23), it is important to de-
scribe all supplement use. Therefore, we analyzed these individu-
al therapies and 3 CAM indices; all CAM, excluding multivitam-
ins or minerals, and further excluding singular vitamin and miner-
al supplements.
Demographic and psychosocial characteristics were examined for
confounding effects. A priori confounders included respondent-re-
ported race/ethnicity, sex, age, employment status in the previous
year (yes/no), imputed family income, and highest level of educa-
tion. Hypothesized confounders included region, body mass index
(BMI), marital status, and the following in the past 12 months:
feeling frequently  stressed and/or  anxious (yes/no),  perceived
health status (fair or poor vs excellent to good), and fatigue (yes/
no).
Frequencies analysis and bivariable and multivariable analyses
were performed to assess the association between the presence of
multiple chronic conditions and CAM use. Each CAM therapy
was analyzed in separate unadjusted and adjusted Poisson regres-
sion models with a robust error variance that estimated the relat-
ive risk of CAM use, comparing participants with 1 and 2 or more
chronic conditions with participants with no chronic conditions
(the reference group). Bonferroni procedures (24) were used to ac-
count for multiple comparisons; the standard α level of 5% was di-
vided by 17 (the total number of specific CAM therapies plus the
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CAM index) to create a corrected α level of .003. Data on chela-
tion therapy was not shown because of the small sample size (n =
17). The relationship between the CAM index and multiple chron-
ic conditions was determined by using a linear regression model
adjusted for confounders. Confounders to be included in the final
models were identified by using the minimally adjusted models,
which  included  all  a  priori  confounders.  Hypothesized  con-
founders were added to minimally adjusted models for all of the
separate CAM outcomes. The variables that appreciably changed
the parameter estimates by 10% were included in all of the final
models. Multicollinearity of predictors was assessed for the final
adjusted models by examining tolerance and variance inflation
factor characteristics in a linear regression model (25). Tolerance
and variance inflation factors are statistical values that describe the
percentage by which 1 predictor is explained by the other predict-
ors in the model. Values of tolerance below 10% and variance in-
flation factor above 10 indicate potential collinearity. Missing cov-
ariates were not imputed and were excluded from individual re-
gression models. All regression analyses were weighted on the
basis of the complex NHIS sampling survey procedure (26), using
SAS software version 9.3 (SAS Institute Inc).
Results
Chronic conditions were common in the US population as sampled
in the 2012 NHIS, where 22.3% of adults reported 1 condition and
33.8% reported 2 or more conditions; therefore, more than half
(56.1%) reported at least 1 chronic condition (Table 1). Of the par-
ticipants with 2 or more chronic conditions, most had 2 conditions
(42.3%), followed by 3 (27.5%) and 4 (15.9%) conditions (data
not shown).  The average age of participants was 48 years and
most adults were non-Hispanic white (67.2%), female (51.8%),
and employed (66.5%). Compared with adults with no chronic
conditions, adults with multiple chronic conditions were older, had
a lower income, were less educated, were unemployed, were more
likely to be obese, and reported having worse perceived health
status and being frequently stressed or anxious.
CAM use was common in the US population.  The 4 most fre-
quently  used  therapies  in  the  past  year  were  multivitamins
(52.7%), vitamins (34.8%), minerals (28.4%), and nonvitamin or
herbal therapies (17.9%) (Table 2). Adults with multiple chronic
conditions reported using on average 2.0 CAM therapies in the last
year. Compared with adults with 1 condition or no chronic condi-
tions, adults with multiple chronic conditions reported higher fre-
quency of multivitamin or multimineral use (57.1%), vitamins
(42.8%),  minerals  (37.5%),  nonvitamin  or  herbal  therapies
(22.0%), chiropractic or osteopathic manipulation (10.1%), mas-
sage (9.7%), special diets (3.6%), and acupuncture (1.9%). Con-
versely, adults with multiple chronic conditions reported using
mind–body and movement therapy less often than those with no
chronic conditions or one chronic condition (Table 2).
After controlling for a priori confounders of age, sex, race, family
income, employment status, and education, adults with 2 or more
chronic conditions were more likely than adults with no chronic
conditions to report using multivitamins/minerals, minerals, vit-
amins,  nonvitamin  or  herbal  therapies,  mind–body  therapies,
chiropractic or osteopathic manipulation, massage, and special di-
ets  (Table  3).  In  models  adjusted  for  additional  confounding
factors, the relationships persisted in all outcome models, and the
positive association between multiple chronic conditions and use
of movement therapy, acupuncture, and naturopathy became signi-
ficant (Table 3).
For the CAM index, after adjustment, adults with multiple condi-
tions used significantly more CAM therapies than adults with no
chronic conditions. No collinearity between predictors was ob-
served for the final adjusted models (data not shown). Sensitivity
analyses, examining more conservative definitions of CAM, resul-
ted in smaller β coefficients. However, these definitions showed
the same overall relationship as the all-inclusive CAM index (Ta-
ble 3).
Discussion
Results from the 2012 National Health Interview Survey showed
more than half of US adults had at least one chronic condition and
over a third had 2 or more chronic conditions. Dietary supple-
ments were used most commonly. In multivariable models we ob-
served that adults with multiple conditions were more likely to re-
port using multiple forms of CAM therapies within the previous
12 months.
Previous studies using the NHIS CAM questionnaire in 2002 and
2007 reported similar associations between specific chronic condi-
tions and CAM use, but no prior analysis has examined use in 13
simultaneous chronic conditions (6,7,10,11,27). In 2002, adults
with asthma (7), cancer (6), diabetes (11), and at least one of 5
specific chronic conditions (arthritis, cancer, cardiovascular dis-
ease, diabetes, and lung disease) (27) reported higher CAM use
than people with no chronic conditions. A study examining both
the 2002 and 2007 NHIS data set also found that among adults
with diabetes, participants with functional limitations or 3 or more
conditions were more likely to use CAM (10). These studies are
similar to the results of our analyses, where adults with multiple
conditions reported a higher likelihood of CAM use.
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Our study differs from previously reported NHIS studies in the
definition of chronic condition, the definition of CAM, and in the
choice of statistical model. First, prior studies vary in their defini-
tions of chronic conditions. Many of these studies examined sin-
gular chronic conditions or a limited number of chronic condi-
tions. Our study has an inclusive definition of multiple chronic
conditions. Second, our study examines specific CAM therapies as
opposed to other studies, which have focused on combined vari-
ables for any CAM therapy. Last, previous studies used odds ra-
tios as compared with risk ratios. The epidemiological convention
for point estimates states that when prevalence is more than 10%,
the odds ratio will show an overestimated measure of association
in comparison to the risk ratio, so the risk ratio should be used
(28). Risk ratios were used in this analysis because many of the
specific CAM therapies were reported as being used by more than
10% of the population. Although one cannot compare the specific
estimates, the general direction of the association is consistent
between our analysis and previous analyses. Additionally, these
studies report data from the 2002 and 2007 surveys, suggesting
this study’s results support an ongoing trend of CAM use in asso-
ciation with chronic conditions. To our knowledge, this is the first
study to examine the likelihood of specific CAM modality use by
multiple chronic conditions as defined by DHHS (4).
A major strength of this study is the examination of CAM use as
separate therapies. CAM is a group of separate behaviors that have
differing intensity, effectiveness, and adverse effects. When these
behaviors are combined into one overall CAM construct, informa-
tion is lost regarding the direction of effect for specific therapies.
Examining specific CAM therapies allowed us to parse out specif-
ic self-care and disease management behaviors among adults with
chronic conditions. Our results showed that not all CAM therapies
are associated with chronic conditions or multiple chronic condi-
tions and further support the decision to examine CAM use as spe-
cific therapies rather than one overarching construct.
There are also limitations to note. First, the NHIS is a cross-sec-
tional study, so temporality between chronic conditions and spe-
cific  CAM use  cannot  be  determined.  One  possibility  is  that
chronic conditions influence people to use specific CAM ther-
apies. Conversely, it is also possible that the CAM use precedes
the development of a chronic condition. Second, there may be se-
lection bias; the NHIS process excludes hospitalized and institu-
tionalized  people,  causing  an  underestimation  of  adults  with
chronic illnesses as well as the most severe chronic conditions.
This selection bias causes the sample to have proportionally more
healthy  people  than are  in  the  US population  and more  parti-
cipants that have the ability to access CAM therapies, causing a bi-
as toward the null. Third, both chronic disease status and CAM
use is self-reported, resulting in potential misclassification and re-
call bias. Lastly, this data set does not include frequency of CAM
modality use. If an individual used a modality once in the past
year, they would be considered users, as would someone who uses
these therapies weekly or daily. This causes an issue of determin-
ing what constitutes CAM behaviors. If the users who do not use a
modality frequently in truth should be considered nonusers then
there is nondifferential misclassification of outcome, biasing the
association toward the null. In addition, there may be people with
chronic conditions who discontinue CAM within the past year be-
cause of factors related to their disease status, which would over-
estimate the number of regular CAM users.
Multiple chronic conditions increase health care costs not only for
the individual but also for the health care system. People with
many conditions must navigate the health-care system to coordin-
ate disease management, which often requires regular visits to dif-
ferent medical specialists. This increases the cost for the patient
and health-care spending.  People with multiple conditions ac-
count for approximately 66% of total health care costs (3). DHHS
has created 4 goals to improve factors related to multiple chronic
conditions, including changes to the health care system; empower-
ing people with multiple conditions by creating community well-
ness programs; providing clinicians with education, training, and
clinical practice guidelines; and improving research practices to
include a focus on comorbid conditions as opposed to specific dis-
eases (29).
Research on CAM use among people with comorbid conditions
can provide information in support of the DHHS goals. The high
use of dietary supplements among people with comorbid condi-
tions is of major importance in disease management because of
potential drug interactions. More research is needed to understand
the efficacy of supplements and how they interact with standard
chronic condition treatments. In addition, we observed high use of
practitioner-based CAM. To improve disease management,  an
open dialogue between CAM practitioners and medical profes-
sionals could help improve decisions on care for patients with
multiple chronic conditions. Additional research will help provide
clinicians with evidence-based guidelines and lower health-care
reimbursements. Therapies with an evidence base for improved
health outcomes in this population could also be integrated into
community wellness programs.
In summary, using data from a population-based sample of US
adults, we found that adults with multiple chronic conditions have
an increased likelihood of using specific types of CAM, including
dietary supplements, mind–body therapies, chiropractic or osteo-
pathic manipulation, massage, movement therapies, special diets,
acupuncture, and naturopathy. Because adults with chronic condi-
tions have an increased likelihood of using specific CAM ther-
PREVENTING CHRONIC DISEASE VOLUME 13, E61
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY             MAY 2016
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
4       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2016/15_0501.htm
apies, in the face of unclear evidence, it is important to conduct
CAM research on people with multiple chronic conditions and not
only populations with specific diseases. Chronic condition man-
agement is an integral part in improving mortality and reducing
illness among people with chronic conditions. Further research
should focus on the efficacy of these therapies in individuals with
multiple  chronic  conditions  and on interactions  with  standard
chronic disease treatments.
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Tables
Table 1. Population Characteristics by Number of Chronic Conditions, National Health Interview Survey, 2012
Characteristic
No. of Chronic Conditions
P b
Total Study Population 0 Chronic Conditions 1 Chronic Condition ≥2 Chronic Conditions
n % (95% CI)a n % (95% CI)a n % (95% CI)a n % (95% CI)a





































2,078 5.2 (4.9–5.5) 1,164 6.9
(6.4–7.5)
386 4.5 (4.0–5.1) 528 3.4
(3.0–3.9)
Other race
363 0.8 (0.6–1.0) 156 0.8
(0.6–1.0)


































































































Abbreviations: CI, confidence interval; NA, not applicable.
a Each n reported in the table is not weighted, but all percentages are weighted.
b Rao-Scott χ2 tests were used to assess associations between population characteristics and number of chronic conditions.
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(continued)
Table 1. Population Characteristics by Number of Chronic Conditions, National Health Interview Survey, 2012
Characteristic
No. of Chronic Conditions
P b
Total Study Population 0 Chronic Conditions 1 Chronic Condition ≥2 Chronic Conditions











3,257 6.2 (5.9–6.5) 389 1.7
(1.5–1.9)










































































































































Body mass index, kg/m2
Abbreviations: CI, confidence interval; NA, not applicable.
a Each n reported in the table is not weighted, but all percentages are weighted.
b Rao-Scott χ2 tests were used to assess associations between population characteristics and number of chronic conditions.
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Table 1. Population Characteristics by Number of Chronic Conditions, National Health Interview Survey, 2012
Characteristic
No. of Chronic Conditions
P b
Total Study Population 0 Chronic Conditions 1 Chronic Condition ≥2 Chronic Conditions






















































































Abbreviations: CI, confidence interval; NA, not applicable.
a Each n reported in the table is not weighted, but all percentages are weighted.
b Rao-Scott χ2 tests were used to assess associations between population characteristics and number of chronic conditions.
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Table 2. Use of CAM in the Past 12 Months by Number of Chronic Conditions, National Health Interview Survey, 2012
CAM Index, Mean (SE)
Total Study Population (n
= 33,557)
0 Chronic Conditions (n
= 13,790)
1 Chronic Condition (n
= 7,427)
≥2 Chronic Conditions (n
= 12,340)
P bMeana 95% CI (SE) Meana 95% CI (SE) Meana 95% CI (SE) Meana 95% CI (SE)
All CAM 1.8 1.8–1.8 (0.02) 1.5 1.5–1.6 (0.02) 1.9 1.9–2.0 (0.03) 2.0 2.0–2.1 (0.02) <.001
Excluding multivitamins 1.3 1.2–1.3 (0.01) 1.0 1.0–1.1 (0.02) 1.4 1.3–1.4 (0.02) 1.5 1.4–1.5 (0.02) <.001
Excluding multivitamins,
vitamins and minerals
0.6 0.6–0.7 (0.01) 0.6 0.5–0.6 (0.01) 0.7 0.7–0.7 (0.02) 0.7 0.6–0.7 (0.02) <.001
Specific CAM therapies N % (CI)a n % (CI)a n % (CI)a n % (CI)a P b
Multivitamin or
multimineral





























2,618 22.0 (20.8–23.1 <.001
Mind–body therapy









2,993 9.1 (8.7–9.5) 991 7.5 (6.9–8.1) 776 10.7
(9.8–11.6)
1,226 10.1 (9.4–10.8) <.001
Massage 2,951 8.8 (8.4–9.2) 1,094 7.8 (7.2–8.4) 716 9.4 (8.6–10.3) 1,141 9.7 (9.0–10.4) <.001
Movement therapy 2,162 6.6 (6.2–7.0) 974 7.2 (6.5–7.8) 584 7.8 (7.1–8.5) 604 5.0 (4.5–5.6) <.001
Special diets 1,027 3.0 (2.8–3.3) 341 2.4 (2.0–2.7) 266 3.4 (2.9–4.0) 420 3.6 (3.1–4.1) <.001
Homeopathy 718 2.2 (2.0–2.4) 270 2.1 (1.8–2.4) 185 2.6 (2.1–3.1) 263 2.1 (1.8–2.5) .1
Acupuncture 604 1.6 (1.4–1.8) 196 1.3 (1.1–1.5) 142 1.8 (1.4–2.1) 266 1.9 (1.6–2.2) .002
Naturopathy 276 0.7 (0.6–0.8) 96 0.6 (0.5–0.8) 75 0.7 (0.5–1.0) 105 0.9 (0.7–1.0) .15
Traditional healing 170 0.4 (0.4–0.5) 67 0.5 (0.3–0.6) 35 0.4 (0.2–0.5) 68 0.5 (0.3–0.6) .70
Craniosacral therapy 109 0.3 (0.2–0.4) 37 0.3 (0.2–0.4) 25 0.2 (0.1–0.3) 47 0.3 (0.2–0.5) .50
Ayurvedic medicine 96 0.3 (0.2–0.3) 45 0.3 (0.2–0.5) 25 0.2 (0.1–0.3) 26 0.2 (0.1–0.3) .10
Abbreviations: CAM, complementary and alternative medicine; CI, confidence interval; SE, standard error.
a Each n reported in the table is not weighted, but all averages and percentages are weighted.
bP values for association between CAM therapies and number of chronic conditions. Rai-Scott χ2 tests and univariable linear regression models used for categoric-
al and continuous variables, respectively.
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Table 3. Association Between CAM Use and Number of Chronic Conditions, National Health Interview Survey, 2012
CAM Modality Outcome Measuresa
Unadjusted Models Minimally Adjustedb Models Final Adjustedc Models
No. of Chronic Conditions No. of Chronic Conditions No. of Chronic Conditions
0 1 ≥2 0 1 ≥2 0 1 ≥2
n = 13,790 n = 7,427 n = 12,340 n = 13,790 n = 7,427 n = 12,340 n = 13,790 n = 7,427 N = 12,340
CAM indexes, β coefficient (95% CI)d
All CAM
Ref 0.4e 0.5e Ref 0.3e 0.6e Ref 0.3e 0.6e
(0.3–0.4) (0.5–0.6) (0.3–0.4) (0.5–0.6) (0.3–0.4) (0.6–0.7)
Excluding multivitamins/minerals
Ref 0.3e 0.4e Ref 0.3e 0.5e Ref 0.3e 0.5e
(0.3–0.4) (0.4–0.5) (0.2–0.3) (0.4–0.5) (0.2–0.3) (0.5–0.6)
Excluding multivitamins, vitamins, and minerals
Ref 0.1e 0.1e Ref 0.1e 0.2e Ref 0.1e 0.2e
(0.1–0.2) (0.1–0.1) (0.1–0.2) (0.2–0.2) (0.1–0.2) (0.2–0.3)
Specific CAM therapies, RR (95% CI)f
Multivitamin or multimineral
Ref 1.1e 1.2e Ref 1.1g 1.1e Ref 1.1e 1.2e
(1.1–1.2) (1.1–1.2) (1.0–1.1) (1.1–1.2) (1.0–1.1) (1.1–1.2)
Mineral
Ref 1.4e 1.8e Ref 1.2e 1.4e Ref 1.2e 1.4e
(1.3–1.5) (1.7–1.9) (1.1–1.3) (1.3–1.5) (1.1–1.3) (1.4–1.5)
Vitamin
Ref 1.3e 1.6e Ref 1.2e 1.4e Ref 1.2e 1.4e
(1.3–1.4) (1.5–1.6) (1.2–1.3) (1.3–1.5) (1.2–1.3) (1.3–1.5)
Nonvitamin or herbal therapies
Ref 1.5e 1.6e Ref 1.4e 1.7e Ref 1.4e 1.7e
(1.4–1.6) (1.5–1.7) (1.3–1.5) (1.5–1.8) (1.3–1.6) (1.6–1.9)
Mind–body therapy
Ref 1.1h 0.9 e Ref 1.2e 1.4e Ref 1.3e 1.6e
(1.0–1.2) (0.8–0.9) (1.1–1.4) (1.3–1.6) (1.2–1.4) (1.4–1.7)
Abbreviations: CAM, complementary and alternative medicine; CI, confidence interval; RR, relative risk.
a Each modality was run as a separate relative risk regression model.
b Adjusted for age, sex, race, income, employment status, and education.
c Adjusted for age, sex, race, income, employment status, education, body mass index, and marital status.
d Values are β (95% CI).
eP value <.001 (α = .003 after Bonferroni adjustment for multiple comparisons).
f Values are RR (95% CI).
gP value <.003 (α = .003 after Bonferroni adjustment for multiple comparisons).
hP value >.003 (α = .003 after Bonferroni adjustment for multiple comparisons).
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(continued)
Table 3. Association Between CAM Use and Number of Chronic Conditions, National Health Interview Survey, 2012
CAM Modality Outcome Measuresa
Unadjusted Models Minimally Adjustedb Models Final Adjustedc Models
No. of Chronic Conditions No. of Chronic Conditions No. of Chronic Conditions
0 1 ≥2 0 1 ≥2 0 1 ≥2
n = 13,790 n = 7,427 n = 12,340 n = 13,790 n = 7,427 n = 12,340 n = 13,790 n = 7,427 N = 12,340
Chiropractic or osteopathic manipulation
Ref 1.4e 1.3e Ref 1.3e 1.4e Ref 1.3e 1.4e
(1.3–1.6) (1.2–1.5) (1.2–1.5) (1.2–1.6) (1.2–1.5) (1.2–1.6)
Massage
Ref 1.2g 1.2e Ref 1.3e 1.8e Ref 1.3e 1.9e
(1.1–1.4) (1.1–1.4) (1.1–1.4) (1.6–2.1) (1.2–1.5) (1.7–2.2)
Movement therapy
Ref 1.1h 0.7e Ref 1.2h 1.2h Ref 1.3e 1.3e
(1.0–1.2) (0.6–0.8) (1.1–1.4) (1.0–1.4) (1.1–1.4) (1.1–1.5)
Special diets
Ref 1.5e 1.5e Ref 1.5e 1.9e Ref 1.5e 1.8e
(1.2–1.8) (1.3–1.8) (1.2–1.9) (1.5–2.4) (1.2–1.9) (1.5–2.4)
Homeopathy
Ref 1.2h 1.0 h Ref 1.3h 1.3h Ref 1.3h 1.4h
(1.0–1.6) (0.8–1.3) (1.0–1.6) (1.0–1.7) (1.0–1.7) (1.0–1.8)
Acupuncture
Ref 1.4h 1.5e Ref 1.3h 1.6h Ref 1.3h 1.8e
(1.0–1.8) (1.2–1.9) (1.0–1.8) (1.2–2.1) (1.0–1.8) (1.3–2.4)
Naturopathy
Ref 1.2h 1.4h Ref 1.3h 2.0h Ref 1.4h 2.4e
(0.9–1.8) (1.0–2.0) (0.9–2.0) (1.3–3.2) (0.9–2.1) (1.5– 3.8)
Traditional healers
Ref 0.8h 1.0h Ref 1.1h 1.9h Ref 1.1h 1.9h
(0.5–1.3) (0.6–1.5) (0.6–1.9) (1.1–3.2) (0.6–2.0) (1.1–3.2)
Craniosacral
Abbreviations: CAM, complementary and alternative medicine; CI, confidence interval; RR, relative risk.
a Each modality was run as a separate relative risk regression model.
b Adjusted for age, sex, race, income, employment status, and education.
c Adjusted for age, sex, race, income, employment status, education, body mass index, and marital status.
d Values are β (95% CI).
eP value <.001 (α = .003 after Bonferroni adjustment for multiple comparisons).
f Values are RR (95% CI).
gP value <.003 (α = .003 after Bonferroni adjustment for multiple comparisons).
hP value >.003 (α = .003 after Bonferroni adjustment for multiple comparisons).
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(continued)
Table 3. Association Between CAM Use and Number of Chronic Conditions, National Health Interview Survey, 2012
CAM Modality Outcome Measuresa
Unadjusted Models Minimally Adjustedb Models Final Adjustedc Models
No. of Chronic Conditions No. of Chronic Conditions No. of Chronic Conditions
0 1 ≥2 0 1 ≥2 0 1 ≥2
n = 13,790 n = 7,427 n = 12,340 n = 13,790 n = 7,427 n = 12,340 n = 13,790 n = 7,427 N = 12,340
Ref 0.8h 1.2h Ref 0.7h 1.2h Ref 0.7h 1.4h
(0.4–1.5) (0.7–2.0) (0.3–1.4) (0.6–2.7) (0.4–1.5) (0.6–3.1)
Ayurvedic medicine
Ref 0.7h 0.5h Ref 0.7h 0.6h Ref 0.7h 0.6h
(0.4– 1.2) (0.3– 1.0) (0.4– 1.2) (0.3– 1.3) (0.4– 1.3) (0.3–1.3)
Abbreviations: CAM, complementary and alternative medicine; CI, confidence interval; RR, relative risk.
a Each modality was run as a separate relative risk regression model.
b Adjusted for age, sex, race, income, employment status, and education.
c Adjusted for age, sex, race, income, employment status, education, body mass index, and marital status.
d Values are β (95% CI).
eP value <.001 (α = .003 after Bonferroni adjustment for multiple comparisons).
f Values are RR (95% CI).
gP value <.003 (α = .003 after Bonferroni adjustment for multiple comparisons).
hP value >.003 (α = .003 after Bonferroni adjustment for multiple comparisons).
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